Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human TPH2 ELISA Kit (AC3860)
Cat.#: ASET-2449
Specifications
Description Human TPH2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human TPH2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.71 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1754 Human TRPV2 ELISA Kit (AC3165) Quantitative inquiry ASET-1955 Rat Cannabinoid Receptor I ELISA Kit (AC3366) Quantitative inquiry ASET-2192 Human CRHR2 ELISA Kit (AC3603) Quantitative inquiry ASET-1978 Bovine TIMP1 ELISA Kit (AC3389) Quantitative inquiry ASET-2253 Mouse Fat3 ELISA Kit (AC3664) Quantitative inquiry ASET-2090 Human PCDHB16 ELISA Kit (AC3501) Quantitative inquiry ASET-1499 Human Neuroligin 1 ELISA Kit (AC2910) Quantitative inquiry ASET-1550 Human TAS2R38 ELISA Kit (AC2961) Quantitative inquiry ASET-1447 Human RAMP1 ELISA Kit (AC2858) Quantitative inquiry ASET-1967 Human Estrogen Receptor beta ELISA Kit (AC3378) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket